GTN
Bringing a single new drug to the market costs $2.9bn, often delivering an intervention that barely differs from those already in the market. Projections into the future are not promising, with an expected 50% drop in R&D output every nine years. At GTN they are searching the astronomically large space of drug-like molecules with their unique patented technology, Generative Tensorial Networks. Their software combines and builds upon techniques from machine learning and quantum physics to simulate, filter and search for molecules, halving development costs and discovering molecules entirely hidden from view.
GTN
Industry:
Biotechnology Chemical Machine Learning Quantum Computing
Founded:
2017-05-17
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gtn.ai
Total Employee:
1+
Status:
Closed
Email Addresses:
[email protected]
Total Funding:
2.84 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Mobile Non Scaleable Content Nginx DigiCert SSL CloudFront Japanese Yen Google Adsense CPanel
Current Advisors List
Founder
Investors List
Isomer Capital
Isomer Capital investment in Seed Round - GTN
Entrepreneur First
Entrepreneur First investment in Seed Round - GTN
Octopus Ventures
Octopus Ventures investment in Seed Round - GTN
AI Seed
AI Seed investment in Seed Round - GTN
Pentech Ventures
Pentech Ventures investment in Seed Round - GTN
Newest Events participated
Official Site Inspections
http://www.gtn.ai
- Host name: 104.247.81.52
- IP address: 104.247.81.52
- Location: Canada
- Latitude: 43.6319
- Longitude: -79.3716
- Timezone: America/Toronto